| +0.02 / +1.32%|
DURECT Corp. is a specialty pharmaceutical company. The company is engaged in development of pharmaceutical products for pain and chronic diseases based on its proprietary drug delivery technology platforms. It manufactures and sells osmotic pumps used in laboratory research, and designs, develops and manufactures a wide range of biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products. It also conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. DURECT was founded by James E. Brown and Felix Theeuwe on February 6, 1998 and is headquartered in Cupertino, CA.
|Felix Theeuwes||Chairman & Chief Scientific Officer|
|James E. Brown||President, Chief Executive Officer & Director|
|Judy Joice||VP-Operations & Corporate Quality Assurance|
|Matthew J. Hogan||CFO, Secretary, CAO & Head-Investor Relations|
|Su Il Yum||EVP-Pharmaceutical Systems Research & Development|